Golden State Wealth Management’s Biogen BIIB Stock Holding History

Golden State Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.2K	Hold	260	–	–	0.01%	699
2026 Q1	$47.7K	Sell	260 -5	-2%	-$921	0.01%	698
2025 Q4	$46.6K	Hold	265	–	–	﹤0.01%	710
2025 Q3	$37.1K	Hold	265	–	–	﹤0.01%	747
2025 Q2	$33.3K	Hold	265	–	–	﹤0.01%	738
2025 Q1	$36.3K	Hold	265	–	–	0.01%	660
2024 Q4	$40.5K	Buy	+265	New	+$44.7K	0.01%	621
2021 Q2	–	Sell	-736	Closed	-$205K	–	308
2021 Q1	$205K	Sell	736 -188	-20%	-$50.7K	0.07%	195
2020 Q4	$226K	Buy	+924	New	+$238K	0.07%	217
2020 Q2	–	Sell	-313	Closed	-$99K	–	269
2020 Q1	$99K	Buy	+313	New	+$95K	0.04%	249
2019 Q4	–	Sell	-693	Closed	-$161K	–	142
2019 Q3	$161K	Sell	693 -55	-7%	-$12.8K	0.05%	232
2019 Q2	$174K	Buy	748 +12	+2%	+$2.77K	0.06%	241
2019 Q1	$174K	Buy	+736	New	+$232K	0.06%	243

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Golden State Wealth Management's BIIB Position: Q2 2026 in Review

Golden State Wealth Management held its Biogen (BIIB) position steady in Q2 2026 at 260 shares worth $56.2K. The position accounts for 0.01% of the portfolio, ranked #699.

Golden State Wealth Management first reported a position in BIIB in Q1 2019 and has held it in 13 quarters since. The position peaked at $226K in Q4 2020. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Golden State Wealth Management held 260 shares of Biogen worth $56.2K as of Q2 2026.
Golden State Wealth Management left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.01% of Golden State Wealth Management's portfolio in Q2 2026, its #699 holding.
Golden State Wealth Management first reported a position in Biogen in Q1 2019 and has held it in 13 quarters since.
Golden State Wealth Management's Biogen position peaked at $226K in Q4 2020.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Golden State Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.